Canopy Gwth Q1FY27 Results: Revenue up 13%, gross margin expands
- Net revenue rose 13% YoY to $81.2 million in Q1FY27
- Adjusted gross margin expanded 600 bps to 31% from 25%
- Canadian medical revenue grew 22% to $25.8 million
- Storz & Bickel gross margin jumped to 48% from 29%
- Cash position remains strong at $337 million
*this image is generated using AI for illustrative purposes only.
Canopy Gwth (TSX: WEED) reported first-quarter fiscal 2027 net revenue of $81.2 million, a 13% increase from the same period last year, driven by growth across its cannabis and Storz & Bickel segments.
The company achieved an adjusted gross margin of 31%, up from 25% in Q1FY26, reflecting supply chain optimizations and the integration of MTL Cannabis. Adjusted EBITDA loss narrowed by 59% to $3.2 million.
Financial Performance
Net revenue growth was broad-based, with the cannabis segment rising 14% and Storz & Bickel increasing 6%. The Canadian medical business led performance with a 22% revenue increase to $25.8 million, supported by growing patient counts despite reduced Veterans Affairs reimbursement rates.
| Metric | Q1FY27 | Q1FY26 | Change |
|---|---|---|---|
| Net Revenue | $81.2 million | $71.9 million* | +13% |
| Adjusted Gross Margin | 31% | 25% | +600 bps |
| Adjusted EBITDA Loss | $3.2 million | $7.8 million* | -59% |
| Cash Position | $337 million | N/A | N/A |
*Prior year figures derived from stated percentage changes.
Storz & Bickel delivered a gross margin of 48%, significantly higher than the 29% recorded in Q1FY26. This improvement was attributed to operational efficiencies and tariff refunds, with management noting that margins remained substantially ahead of prior-year levels even excluding tariff impacts.
Segment Highlights
Canadian adult-use revenue rose 10% to $29.7 million, building on 20% growth in FY26. Market share data indicates Canopy Gwth moved to number six overall, up from eight, and secured top-two positions in premium flower and infused pre-rolls.
International cannabis revenue increased 10%, driven by strong sales in Poland where the company is now a top-three supplier. This marks the third consecutive quarter of sequential international growth. The company plans to begin flower shipments to the UK imminently, with revenue contributions expected in the second half of fiscal 2027.
What the Numbers Show
The divergence between reported and adjusted gross margins highlights the impact of acquisition-related accounting adjustments. Reported gross margin stood at 22%, compared to an adjusted 31%, due to a $2.6 million non-cash inventory flow-through charge from the MTL acquisition. This suggests that underlying operational profitability is stronger than GAAP figures indicate, as the charge is a one-time item rather than a recurring cost structure issue.
Balance Sheet and Outlook
Cash stood at $337 million as of June 30, 2026. Operating cash used was $25 million, which management described as higher than the expected run rate for fiscal 2027 due to working capital increases and one-time transaction costs.
Management expects consistent operational improvement throughout fiscal 2027, targeting mid-30s adjusted gross margins in the near term. Synergies from the MTL integration are currently tracking at $8 million annually, up from $6 million previously, with a target of $10 million within 18 months of the March closing.
How will the imminent start of UK flower shipments impact Canopy Gwth's international revenue trajectory and market share in Europe during the second half of fiscal 2027?
Given the $337 million cash position, will Canopy Gwth prioritize debt reduction, share buybacks, or further strategic acquisitions to capitalize on its improved cash flow?
Can the company sustain mid-30s adjusted gross margins as it scales up production, or will increased volume pressure margins due to competitive pricing dynamics?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
